Aciclovir Intravenous (DBL) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: glycomacropeptide formula with amino acids and low phenylalanine
Brand name
(ARTG)
: DBL Aciclovir 250mg/10mL Intravenous infusion injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Aciclovir Intravenous Infusion is indicated for the purpose of 1. Promoting resolution of acute clinical manifestations of mucocutaneous Herpes simplex virus infections in immunocompromised patients. 2. Treatment of severe first episode primary or non- primary genital herpes in immune competent patients. 3. Treatment of acute manifestations of Varicella zoster virus infection in immunocompromised patients. 4. Treatment of shingles (Varicella zoster virus infection) in immune competent patients who show very severe acute local or systemic manifestations of the disease. Benefits can be expected in patients with rash duration shorter than 72 hours. The use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles. 5. Treatment of Herpes simplex encephalitis.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous Infusion
- Clear, colourless or almost colourless solution, free from visible particulate matter.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 5 x 10mL pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
